Research & Literature

MRI suggests increased tonicity of the levator ani in women with interstitial cystitis/bladder pain syndrome.

Ackerman AL, Lee UJ, Jellison FC, et al.

International urogynecology journal 2016; (27(1)):77-83 doi:10.1007/s00192-015-2794-6.

Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes.

Nickel JC, Mills IW, Crook TJ, et al.

The Journal of urology 2016; (195(4 Pt 1)):942-8.

Use of Botulinum Toxin in Urologic Diseases.

Chermansky CJ, Chancellor MB

Urology 2016; (91()):21-32.

The enigma of men with interstitial cystitis/bladder pain syndrome.

Arora HC, Shoskes DA

Translational andrology and urology 2015; (4(6)):668-76 doi:10.3978/j.issn.2223-4683.2015.10.01.

Similarities between interstitial cystitis/bladder pain syndrome and vulvodynia: implications for patient management.

Fariello JY, Moldwin RM

Translational andrology and urology 2015; (4(6)):643-52 doi:10.3978/j.issn.2223-4683.2015.10.09.

The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome.

Pang R, Ali A

Translational andrology and urology 2015; (4(6)):653-61 doi:10.3978/j.issn.2223-4683.2015.08.10.

Complementary and alternative medical therapies for interstitial cystitis: an update from the United States.

Atchley MD, Shah NM, Whitmore KE

Translational andrology and urology 2015; (4(6)):662-7 doi:10.3978/j.issn.2223-4683.2015.08.08.

Somatic symptoms are sensitive in predicting interstitial cystitis/bladder pain syndrome.

Chen IC, Lee M, Wu SL, et al.

International journal of psychiatry in medicine 2017; (52(1)):48-61 doi:10.1177/0091217417703286.

Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.

Crescenze IM, Tucky B, Li J, et al.

Urology 2017; (107()):49-54 doi:10.1016/j.urology.2017.05.016.

Development of an interstitial cystitis risk score for bladder permeability.

Lamb LE, Janicki JJ, Bartolone SN, et al.

PloS one 2017; (12(10)):e0185686 doi:10.1371/journal.pone.0185686.

Impact of Cystectomy With Urinary Diversion Upon Tracked Receipt of Opioid Prescriptions Among Patients With Interstitial Cystitis/Bladder Pain Syndrome.

Koslov DS, Vilson F, Colaco M, et al.

Urology 2018; (114()):83-86 doi:10.1016/j.urology.2017.11.009.

Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome.

Lee MH, Chang KM, Tsai WC

International urogynecology journal 2018; (29(7)):1045-1050 doi:10.1007/s00192-018-3574-x.

Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome.

Jhang JF, Hsu YH, Peng CW, et al.

The Journal of urology 2018; (200(3)):590-596 doi:10.1016/j.juro.2018.03.133.

Current Therapeutic Strategies in Clinical Urology.

Crane A, Isharwal S, Zhu H

Molecular pharmaceutics 2018; (15(8)):3010-3019 doi:10.1021/acs.molpharmaceut.8b00383.

Cystoscopic evaluation and clinical phenotyping in interstitial cystitis/bladder pain syndrome

Acar Ö, Tarcan T

Journal of the Turkish German Gynecological Association 2019; (20(2)):117-122 doi:10.4274/jtgga.galenos.2018.2018.0102.

Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.

Zhang P, Wang JY, Zhang Y, et al.

Neuromodulation : journal of the International Neuromodulation Society 2019; (22(6)):730-737 doi:10.1111/ner.12902.

Risk factors for increased serum creatinine level in patients with psoriasis treated with cyclosporine in a real-world practice.

Hong JR, Lee YW, Choe YB, Ahn KJ

Dermatologic therapy 2019; (32(3)):e12875 doi:10.1111/dth.12875.

Interstitial cystitis, bladder pain syndrome, hypersensitive bladder, and interstitial cystitis/bladder pain syndrome - clarification of definitions and relationships.

Homma Y

International journal of urology : official journal of the Japanese Urological Association 2019; (26 Suppl 1()):20-24 doi:10.1111/iju.13970.

Pathophysiology of interstitial cystitis.

Birder LA

International journal of urology : official journal of the Japanese Urological Association 2019; (26 Suppl 1()):12-15 doi:10.1111/iju.13985.

Phenotyping of interstitial cystitis/bladder pain syndrome.

Akiyama Y, Hanno P

International journal of urology : official journal of the Japanese Urological Association 2019; (26 Suppl 1()):17-19 doi:10.1111/iju.13969.

Phenotypic Spectrum of Pentosan Polysulfate Sodium-Associated Maculopathy: A Multicenter Study.

Hanif AM, Armenti ST, Taylor SC, et al.

JAMA ophthalmology 2019; (137(11)):1275-1282 doi:10.1001/jamaophthalmol.2019.3392.

Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses.

Wallrapp A, Burkett PR, Riesenfeld SJ, et al.

Immunity 2019; (51(4)):709-723.e6 doi:10.1016/j.immuni.2019.09.005.

The Neuropeptide CGRP Induces Bipolar Syndrome in Group 2 Innate Lymphoid Cells.

Motomura Y, Kobayashi T, Moro K

Immunity 2019; (51(4)):598-600 doi:10.1016/j.immuni.2019.09.015.

Predictive Factors for a Satisfactory Treatment Outcome with Intravesical Botulinum Toxin A Injection in Patients with Interstitial Cystitis/Bladder Pain Syndrome.

Wang HJ, Yu WR, Ong HL, Kuo HC

Toxins 2019; (11(11)) doi:10.3390/toxins11110676.

Pulsed Electromagnetic Field Therapy as a Complementary Alternative for Chronic Pelvic Pain Management in an Interstitial Cystitis/Bladder Pain Syndrome Patient.

Overholt TL, Ross C, Evans RJ, Walker SJ

Case reports in urology 2019; (2019()):5767568 doi:10.1155/2019/5767568.

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome.

Jiang T, Zhou X, Chen Z, et al.

BMC urology 2020; (20(1)):36 doi:10.1186/s12894-020-00597-3.

Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Akiyama Y, Luo Y, Hanno PM, et al.

International journal of urology : official journal of the Japanese Urological Association 2020; (27(6)):491-503 doi:10.1111/iju.14229.

Clinical guidelines for interstitial cystitis/bladder pain syndrome.

Homma Y, Akiyama Y, Tomoe H, et al.

International journal of urology : official journal of the Japanese Urological Association 2020; (27(7)):578-589 doi:10.1111/iju.14234.

Correlates of 1-Year Change in Quality of Life in Patients with Urologic Chronic Pelvic Pain Syndrome: Findings from the Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network.

Clemens JQ, Stephens-Shields AJ, Newcomb C, et al.

The Journal of urology 2020; (204(4)):754-759 doi:10.1097/JU.0000000000001080.

Clinical characterization of interstitial cystitis/bladder pain syndrome in women based on the presence or absence of Hunner lesions and glomerulations.

Watanabe D, Akiyama Y, Niimi A, et al.

Lower urinary tract symptoms 2021; (13(1)):139-143 doi:10.1111/luts.12344.

Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Gracely A, Cameron AP

Drugs & aging 2021; (38(1)):1-16 doi:10.1007/s40266-020-00810-w.

Examination of pelvic floor muscle elasticity in patients with interstitial cystitis/bladder pain syndrome using real-time tissue elastography.

Abe-Takahashi Y, Kitta T, Ouchi M, et al.

International urogynecology journal 2022; (33(3)):619-626 doi:10.1007/s00192-021-04761-7.

The effect of mindfulness-based stress reduction on the urinary microbiome in interstitial cystitis.

Shatkin-Margolis A, White J, Jedlicka AE, et al.

International urogynecology journal 2022; (33(3)):665-671 doi:10.1007/s00192-021-04812-z.

Painful Bladder Syndrome/Interstitial Cystitis and High Tone Pelvic Floor Dysfunction.

Moody CC, Fashokun TB

Obstetrics and gynecology clinics of North America 2021; (48(3)):585-597 doi:10.1016/j.ogc.2021.05.010.

Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics.

Lee YK, Jhang JF, Jiang YH, et al.

Scientific reports 2021; (11(1)):17258 doi:10.1038/s41598-021-96810-w.

The diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies in clinically suspected interstitial cystitis/bladder pain syndrome.

Chen Y, Ying Z, Xiao Y, et al.

European journal of obstetrics, gynecology, and reproductive biology 2021; (265()):156-161 doi:10.1016/j.ejogrb.2021.08.025.

Organ cross-sensitization mechanisms in chronic diseases related to the genitourinary tract.

Majima T, Sassa N

Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi 2021; (57(0)):49-52 doi:10.1540/jsmr.57.49.

Low-pressure hydrodistension induces bladder glomerulations in female patients with interstitial cystitis/bladder pain syndrome.

Hsu LN, Tsai YS, Tong YC

Neurourology and urodynamics 2022; (41(1)):296-305 doi:10.1002/nau.24818.

Prevalence of Overactive Bladder Symptoms Among Women With Interstitial Cystitis/Bladder Pain Syndrome.

Dubinskaya A, Tholemeier LN, Erickson T, et al.

Female pelvic medicine & reconstructive surgery 2022; (28(3)):e115-e119 doi:10.1097/SPV.0000000000001166.

Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.

Mukhopadhyay C, Boyce TM, Gehrs KM, et al.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2022; (11(2)):100-110 doi:10.1097/APO.0000000000000504.

Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

Clemens JQ, Erickson DR, Varela NP, Lai HH

The Journal of urology 2022; (208(1)):34-42 doi:10.1097/JU.0000000000002756.

A pilot study on oral cyclosporine A in association with fulguration for the treatment of interstitial cystitis with Hunner's lesions.

Brière R, Bouchard F, Ismail S, et al.

Neurourology and urodynamics 2022; (41(6)):1498-1504 doi:10.1002/nau.24997.

Editorial: Special Issue "Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)".

Neuhaus J, Gonsior A, Berndt-Paetz M

Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071689.

Clinical Approach to Recurrent Voiding Dysfunction, Dysuria, and Pelvic Pain Persisting for at Least 3 Months.

Kim SJ, Kim KH

International neurourology journal 2022; (26(3)):179-189 doi:10.5213/inj.2244200.100.

Multimodal Treatment with Cognitive Behavioral Therapeutic Intervention Plus Bladder Treatment Is More Effective than Monotherapy for Patients with Interstitial Cystitis/Bladder Pain Syndrome-A Randomized Clinical Trial.

Yu WR, Jhang JF, Chen BY, et al.

Journal of clinical medicine 2022; (11(20)) doi:10.3390/jcm11206221.

Compensatory coping and depression in women with interstitial cystitis/bladder pain syndrome.

Sutherland S, Grace Kelly A, Ryden A, et al.

Neurourology and urodynamics 2023; (42(1)):322-329 doi:10.1002/nau.25089.

Quality-of-life impact of interstitial cystitis and other pelvic pain syndromes.

Cunningham AR, Gu L, Dubinskaya A, et al.

Frontiers in pain research (Lausanne, Switzerland) 2023; (4()):1149783 doi:10.3389/fpain.2023.1149783.

Laser Treatment for Patients With Vulvodynia and Interstitial Cystitis/Bladder Pain Syndrome: A Case Series (The UNICORN-3 Study).

Okui N, Okui MA, Kouno Y, Nakano K

Cureus 2023; (15(7)):e41786 doi:10.7759/cureus.41786.

Serum anandamide and lipids associated with linoleic acid can distinguish interstitial cystitis/bladder pain syndrome from overactive bladder: An exploratory study.

Torimoto K, Ueda T, Gotoh D, et al.

Lower urinary tract symptoms 2023; (15(6)):238-246 doi:10.1111/luts.12501.

Approach of Chronic Pelvic Pain with Top Flat Magnetic Stimulation.

Salsi B, Ganassi G, Lopopolo G, et al.

Advances in urology 2023; (2023()):9983301 doi:10.1155/2023/9983301.

The association between vulvodynia and interstitial cystitis/bladder pain syndrome: A systematic review.

Bosio S, Perossini S, Torella M, et al.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 2024; (167(1)):1-15 doi:10.1002/ijgo.15538.

Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome.

Hu JC, Tzeng HT, Lee WC, et al.

International journal of molecular sciences 2024; (25(15)) doi:10.3390/ijms25158015.

Definition Change and Update of Clinical Guidelines for Interstitial Cystitis and Bladder Pain Syndrome.

Homma Y, Akiyama Y, Kim JH, et al.

Lower urinary tract symptoms 2024; (16(5)):e12532 doi:10.1111/luts.12532.

Novel Application of T1ρ Magnetic Resonance Imaging for Noninvasive Assessment of Bladder Hyperpermeability Biomarkers: A Focus on Glycosaminoglycan Content.

Suyama JA, Statum SM, Mohana-Borges AVR, et al.

Neurourology and urodynamics 2025; (44(5)):1081-1089 doi:10.1002/nau.70058.

Unraveling the complexity of bladder-centric chronic pain by intravesical contrast enhanced MRI.

Tyagi P, Maranchie J, Dhir R, et al.

Continence (Amsterdam, Netherlands) 2023; (7()) doi:10.1016/j.cont.2023.101041.

Interstitial Cystitis/Bladder Pain Syndrome in Men.

Snipes M, Whitman W, Pontari M, et al.

Neurourology and urodynamics 2026; (45(1)):26-31 doi:10.1002/nau.70103.

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: Current Limitations and a Pragmatic Clinical Diagnostic Definition.

Werneburg GT, Moldwin R, Lowell Parsons C, et al.

Neurourology and urodynamics 2026; (45(1)):32-38 doi:10.1002/nau.70112.

Integrative Diagnostic Model Combining Urinary Biomarkers and Clinical Parameters to Improve Diagnostic Performance in Interstitial Cystitis/Bladder Pain Syndrome.

Chen YC, Tian JH, Kuo HC

European urology open science 2025; (82()):192-200 doi:10.1016/j.euros.2025.10.021.

Advances in Cytokines and Inflammatory Mechanisms in the Pathogenesis of Interstitial Cystitis/Bladder Pain Syndrome.

Xiao Y, Zhu D, Zhou X

Biomolecules 2026; (16(1)) doi:10.3390/biom16010138.